Yano Y - Search Results

1

Healthcare Expenditures for the Treatment of Patients Infected with Hepatitis C Virus in Japan.

Fukuda H, Yano Y, Sato D, Ohde S, Noto S, Watanabe R, Takahashi O. Fukuda H, et al. Among authors: yano y. Pharmacoeconomics. 2020 Mar;38(3):297-306. doi: 10.1007/s40273-019-00861-x. Pharmacoeconomics. 2020. PMID: 31761994

2

A crossover study of oral administration of UFT in chronic liver disease: comparison of continuous and intermittent schedules.

Yamashita F, Tanaka M, Fukumori K, Ando E, Yano Y, Kato O, Yamamoto H, Fukuda H, Kusaba T, Tanikawa K, Sata M. Yamashita F, et al. Among authors: yano y. Anticancer Drugs. 1998 Jun;9(5):399-404. doi: 10.1097/00001813-199806000-00005. Anticancer Drugs. 1998. PMID: 9660536 Clinical Trial.

3

Early response to interferon alpha treatment and long-term clinical outcome in Japanese patients with chronic HBV genotype C infection.

Seo Y, Yoon S, Hamano K, Nakaji M, Yano Y, Katayama M, Ninomiya T, Hayashi Y, Kasuga M. Seo Y, et al. Among authors: yano y. Int J Mol Med. 2004 Jan;13(1):75-9. Int J Mol Med. 2004. PMID: 14654974

4

Mutations within enhancer II and BCP regions of hepatitis B virus in relation to advanced liver diseases in patients infected with subgenotype B3 in Indonesia.

Heriyanto DS, Yano Y, Utsumi T, Anggorowati N, Rinonce HT, Lusida MI, Soetjipto, Triwikatmani C, Ratnasari N, Maduseno S, Purnama PB, Nurdjanah S, Hayashi Y. Heriyanto DS, et al. Among authors: yano y. J Med Virol. 2012 Jan;84(1):44-51. doi: 10.1002/jmv.22266. J Med Virol. 2012. PMID: 22095534

5

Short- and long-term outcome of interferon therapy for chronic hepatitis B infection.

Seo Y, Yano Y. Seo Y, et al. Among authors: yano y. World J Gastroenterol. 2014 Oct 7;20(37):13284-92. doi: 10.3748/wjg.v20.i37.13284. World J Gastroenterol. 2014. PMID: 25309065 Free PMC article. Review.

6

Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2.

Seo K, Kim SK, Kim SR, Ohtani A, Kobayashi M, Kato A, Morimoto E, Saijo Y, Kim KI, Imoto S, Kim CW, Yano Y, Kudo M, Hayashi Y. Seo K, et al. Among authors: yano y. Dig Dis. 2017;35(6):541-547. doi: 10.1159/000480145. Epub 2017 Oct 17. Dig Dis. 2017. PMID: 29040986

7

Response to interferon-alpha in chronic hepatitis B with and without precore mutant strain detected by mutation site-specific assay.

Seo Y, Yoon S, Hamano K, Nakaji M, Yano Y, Katayama M, Ninomiya T, Hayashi Y, Kasuga M. Seo Y, et al. Among authors: yano y. J Clin Gastroenterol. 2004 May-Jun;38(5):460-4. doi: 10.1097/00004836-200405000-00013. J Clin Gastroenterol. 2004. PMID: 15100528

8

Long-term follow-up of Japanese patients with chronic hepatitis B treated with interferon-alpha.

Truong BX, Seo Y, Kato M, Hamano K, Ninomiya T, Katayama M, Kato H, Yano Y, Hayashi Y, Kasuga M. Truong BX, et al. Among authors: yano y. Int J Mol Med. 2005 Aug;16(2):279-84. Int J Mol Med. 2005. PMID: 16012762 Clinical Trial.

9

Expression of thioredoxin and thioredoxin-binding protein-2 in the liver of patients with chronic hepatitis C as a predictor of response to interferon therapy.

Hamano K, Seo Y, Kato H, Kato M, Yano Y, Ninomiya T, Kasuga M. Hamano K, et al. Among authors: yano y. Int J Mol Med. 2006 Jun;17(6):989-95. Int J Mol Med. 2006. PMID: 16685406

10

Variations in the core promoter/pre-core region in HBV genotype C in Japanese and Northern Vietnamese patients.

Truong BX, Yano Y, Seo Y, Phuong TM, Tanaka Y, Kato H, Miki A, Utsumi T, Azuma T, Trach NK, Mizokami M, Hayashi Y, Kasuga M. Truong BX, et al. Among authors: yano y. J Med Virol. 2007 Sep;79(9):1293-304. doi: 10.1002/jmv.20934. J Med Virol. 2007. PMID: 17607788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,770 results

Search Page

Filters